on the other hand , there is increasing support for early thrombolytic treatment after myocardial infarction , especially since two multicentre trials have now shown reduced mortality in patients treated with intracoronary streptokinase within 4-6 hours of infarction and a further large multicentre study also demonstrated reduced mortality in patients treated with early intravenous streptokinase .
C0027051
myocardial infarction
C0021308
infarction